Bronchiolitis

5,637 views

Published on

0 Comments
9 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
5,637
On SlideShare
0
From Embeds
0
Number of Embeds
7
Actions
Shares
0
Downloads
312
Comments
0
Likes
9
Embeds 0
No embeds

No notes for slide

Bronchiolitis

  1. 1. BRONCHIOLITIS Alok Kumar, MD
  2. 2.  VA, a 6-month-old, previously well infant, presents to the general practitioner with 2 days of nasal congestion, feeding more slowly than usual but maintaining a normal urine output.
  3. 3.  She is febrile with temperature of 38°C, alert, interactive and not dehydrated. There is chest-wall recession, a elevated respiratory rate of 66 breaths per minute and she is pink in room air. Crackles over right axillary region on chest auscultation.
  4. 4.  Her WBC count is 19.6K, with 82% Neutrophills. Chest Xray show patchy opacities in the right middle lobe.
  5. 5.  Jane has bronchopneumonia and needs admission and antibiotics along with other supportive care.
  6. 6. Case A RG” is a 4-month-old boy who presents with nasal congestion and poor feeding for 2 days. His mother comments that he has not had a wet nappy for at least 8 hours. Henry was born at term and has been thriving. His older brother has had a cold over the last week.
  7. 7.  On examination RG is tachypnoeic (respiratory rate of 68 breaths per minute), tachycardic (152 beats per minute) and mildly febrile (38.6°C). Although he appears pink in room air, his breathing is laboured, with considerable use of accessory muscles of respiration, and he has crackles in both lung fields audible on chest auscultation.
  8. 8.  RG has moderately severe bronchiolitis complicated by dehydration and a likely need for supplemental oxygen. You inform the parents that he will need admission to hospital.
  9. 9. Epidemiology commonest lower respiratory tract infection in children less than 12 months of age and most frequent cause of hospitalization in infants under 6 months of age. Most cases occur in late autumn and early spring, coinciding with the RSV prevalence
  10. 10. Eteopathogenesis It is caused by viral infections of the lower respiratory tract, principally by RSV, small-airway narrowing due to airway edema, resulting in air trapping self-limiting condition, may be life threatening, especially those with pre- existing cardiac/respiratory conditions.
  11. 11.  Reduced lung function may predisposed to bronchiolitis rather than reduced lung function because of bronchiolitis Infants who develop recurrent bouts of wheezing following bronchiolitis may do so because their airways are of smaller calibre or have altered compliance, and these children do not necessarily develop asthma
  12. 12. Diagnosis Bronchiolitis is a clinical diagnosis. breathing difficulty with coryza and cough may present with apnoea Range of severity
  13. 13. Presentation Nasal obstruction ± rhinorrhoea and an irritating cough are noticed first. After 1–3 days there follows increasing tachypnoea and respiratory distress.
  14. 14. Presentation Fever of 38.5°C or greater is seen in 50% Auscultatory signs are very variable inspiratory crackles are often heard expiratory wheeze is often present
  15. 15. Differential diagnosis Asthma pulmonary aspiration, bacterial or viral pneumonia, cardiac failure, cystic fibrosis, sepsis (with apnoea), inhaled foreign body in an older infant
  16. 16. Bronchiolitis v/s early Asthma often a source of confusion the recurrence of wheezing, and factors such as the presence of eczema in an older infant and a history of atopy or asthma in one or both parents or sibling, suggest that the infant is more likely to have asthma.
  17. 17. Bronchiolitis v/s Pneumonia if localised chest findings with radiological changes are present together with neutrophilia on the blood count, then consider a diagnosis of bacterial pneumonia;
  18. 18. Assessment of severityThe severity of bronchiolitis can be assessed as mild, moderate or severe
  19. 19. History pre-existing conditions, including premature birth, chronic respiratory conditions (eg, cystic fibrosis), underlying neurological or neuromuscular conditions, cardiac conditions and immunodeficiency
  20. 20. History duration and rate of progression of symptoms, and how well the infant is feeding
  21. 21. Examination General appearance- flushed and warm (T>38.8°C)- tachycardic (HR>140)- apnic
  22. 22. ExaminationHydration: Is the nappy wet? Are the mucous membranes moist? Is the infant able to feed?
  23. 23. ExaminationDegree of respiratory difficulty: tachypnic (RR>60) using accessory muscles to breathe? crackles or wheezes on chest auscultation?
  24. 24. ExaminationAdequacy of oxygenation: In room air, is the infant pink or centrally cyanosed? Saturation in room air?
  25. 25. Mild Normal or near normal ability to feed Mild respiratory distress with tachypnea and no recession Saturation >95% in room air
  26. 26. Moderate Moderate resp distress with some recession and/or nasal flaring Mild hypoxemia corrected with supplemental O2 Short of breath when feeding Brief apnoeic spell
  27. 27. Severe Unable to feed Severe respiratory distress with marked recession, nasal flaring, grunting Hypoxia not corrected by supplemental O2 Frequent or prolonged apnea Tiring
  28. 28. Factors increasing the likelihood ofhospital admission The presence of one or more ofthese risk factors indicates the need for referral to department with paediatric expertise.
  29. 29. Consider admission History of significant apnoea structural cardiac anomaly pre-existing lung disease (eg, cystic fibrosis) Chronological age less than 6 weeks
  30. 30. Consider admission prematurity (< 32 weeks) and/or chronic neonatal lung disease Modreate or Severe bronchiolitis Significant dehydration
  31. 31. Management of mild viral bronchiolitisNo need for admission and managed at home
  32. 32.  requires explanation and reassurance, but no pharmacological or other therapy [E4] Bronchodilators and, to a lesser extent, systemic corticosteroids are frequently prescribed in general practice
  33. 33.  randomised clinical trials of bronchodilators in viral bronchiolitis, patients, have shown no clear or sustained benefits [E1] Much of the confusion over bronchodilators and corticosteroids relates to the fact that bronchiolitis, transient early wheezing and asthma can produce similar clinical features
  34. 34. Management ofmoderate to severe bronchiolitis Needs admission
  35. 35. Investigations mild bronchiolitis, no investigations are indicated, as they will not influence management [E3] moderate to severe bronchiolitis, the following investigations may be considered in a child in the emergency department [E3, E4]
  36. 36. Investigations Oximetry; Nasopharyngeal aspirate for RSV and viral culture; Chest radiograph: if moderate (or more) respiratory difficulty, or if diagnostic uncertainty (eg, localised signs on chest auscultation or cardiac murmur with signs of congestive cardiac failure);
  37. 37. Investigations Full blood count: if localised radiological changes are present together with neutrophilia on the blood count, then consider a diagnosis of bacterial pneumonia; Electrolyte, urea and creatinine levels, especially if the child needs intravenous fluids;
  38. 38. Investigations Blood culture: if temperature > 38.5°C; and Blood gas levels: oximetry will guide adequacy of oxygenation, although the likelihood of CO2 retention is low for a child who requires an inspired oxygen concentration (Fio2) < 40%.
  39. 39. Oxygenation Supplement O2 to maintain O2 >95% Use humidified oxygen, where possible via nasal prongs (maximum flow rate, 2 L/min), facemask (minimum flow rate, 4 L/min) or headbox. Observe and monitor closely for need for intubation and ventilation
  40. 40. Nutrition Nil by mouth in severe cases, can breast/formula feed in moderate cases IV Fluid in all severe cases and consider supplemental IVF in moderate cases
  41. 41. Nutrition-IVF Intravenous fluids should be administered when there is moderate to severe or severe respiratory difficulty (marked chest wall retraction, nasal flaring, expiratory grunting), marked tachypnoea (> 80 breaths per minute), apnoeic episodes, or visible tiring during feeds [E4].
  42. 42. Nutrition-IVF A balance must be sought between increased fluid requirements with the risks of overhydration and reduced lung compliance. Regular review of hydration status is important.
  43. 43. Monitoring involves the recognition of deterioration that will necessitate treatment. include signs of increasing difficulty with feeding and associated risks of pulmonary aspiration, fatigue, work of breathing, and apnoeic episodes. Additionally, maintaining continuity of oxygen therapy, oxygen saturation (Spo2) and heart rate monitoring,
  44. 44. Intensive care unit care those who progress to severe respiratory difficulty, those from an at-risk group, patients with apnoeic episodes associated with oxygen desaturation (Spo2 < 90%) while receiving more than 40% to 50% inspired oxygen (Fio2), and patients with frequent recurrent brief apnoeic episodes (especially infants < 6 weeks old).
  45. 45. Intensive care unit care Admission to ICU and intubation would be appropriate if blood gases show evidence of respiratory failure despite 40% to 50% inspired oxygen (on arterial blood: Po2 < 60 mmHg; Pco2 > 50 mmHg; pH < 7.25) [E4].
  46. 46. Other therapeutic practices Not proven to be useful
  47. 47. Bronchodilators do not improve oxygen saturation, or affect rate or duration of hospitalisation [E1] modest short-term improvement in clinical scores. Ipratropium bromide has not been shown to be useful in bronchiolitis
  48. 48. Corticosteroids A meta-analysis failed to show sufficient benefit to change current accepted practice (ie, that corticosteroids should not be routine therapy in viral bronchiolitis) [E1] a more recent study demonstrated a modest benefit with high-dose oral dexamethasone in children with mild to moderate bronchiolitis [E2
  49. 49. Adrenaline A recently published Australian RCT demonstrated a lack of efficacy of nebulised adrenaline in infants aged 0 to 12 months with viral bronchiolitis [E2].
  50. 50. Ribavirin The use of ribavirin, with broad-spectrum antiviral activity, is not supported by evidence of significant benefit [E1]
  51. 51. Antibiotics commonly prescribed one small RCT failed to demonstrate any benefit in hospitalised infants with bronchiolitis [E2]
  52. 52. Antibiotics The only role for antibiotics is in complicated bronchiolitis where a secondary bacterial infection is suspected. This is rare, but not easily excluded in a sick infant with fever, toxicity and significant opacities on the chest radiograph [E4].
  53. 53. Antibiotics Unfortunately, antibiotics are most frequently prescribed in children with mild bronchiolitis with minimal chest radiographic changes, such as partial right upper lobe collapse, which are commonplace in uncomplicated RSV bronchiolitis
  54. 54. Other interventions Immunoglobulins no evidence of benefit of intravenous immunoglobulins
  55. 55. Prevention – isalways better than cure! That is if one exists!!!
  56. 56. Palivizumab a human recombinant monoclonal antibody directed against a surface glycoprotein of RSV. monthly injection over the “RSV season”. it does reduce hospitalisation in high risk groups, it did not reduce the incidence of mechanical ventilation [E2]. its efficacy and cost-effectiveness is challenged
  57. 57. RSV-IGIV (Respigam) antibody preparation derived from the sera of adult humans monthly intravenous infusion, it reduced hospitalisation rates, but had the disadvantages of being given intravenously, being expensive, and being considerably less potent than palivizumab in an animal model.
  58. 58. Vaccine There are no vaccines available against RSV
  59. 59. Prevention of RSV cross-infection adequate hand washing by nursing and medical staff, other staff and parents will minimise the risk of cross-infection [E4]. not nursing infants with bronchiolitis (RSV positive, or awaiting RSV test results) in rooms with high-risk infants (unless the latter are also RSV positive) [E4].
  60. 60. Discharge criteria Most infants can be discharged in less than 3 days, depending on their ability to sustain adequate levels of hydration and oxygenation (Spo2 > 90%–92%) and the ability of the parents to attend to the needs of the recovering infant [E3].
  61. 61.  All children admitted to hospital should be reviewed by their general practitioner within 7 days. If persisting cough, tachypnoea or wheeze develops, then review by a paediatrician
  62. 62. Summary Bronchiolitis in infancy is a common Commonest cause of hospital admission in young infants. Most children with develop only mild illness and can be managed at home.
  63. 63. Summary A minority of infants with underlying conditions are at risk of developing more severe illness. Ex-prems, those with cardiac or respiratory disease, and infants in the first 3 months of life are more likely to need admission.
  64. 64. Summary Such infants can usually be identified with history-taking and examination. The presence of crepitations and hypoxaemia at presentation are the best clinical predictors of need for admission.
  65. 65. Summary RSV is responsible for most cases. Secondary bacterial infection is rare and antibiotics are seldom necessary. Nebulised adrenaline, inhaled and systemic corticosteroids, and inhaled bronchodilators not useful in the routine management.

×